
Frankincense Compound Targets Insulin Signaling In Alzheimer's Cell Model
A compound from frankincense resin changed insulin-signaling and inflammation markers in lab-grown neurons exposed to the toxic protein linked to Alzheimer's disease.
- Lab neuron model, not humans
- SIRT6 estimate: -38.26 kcal/mol
- Lower detectable amyloid-beta
Dr. Axe's Take
Frankincense has a long history in traditional medicine for inflammation, and this lab study hints at a modern mechanism: incensole acetate touches the same insulin-signaling and inflammation pathways that go haywire in Alzheimer's disease. The NF-kB drop alongside the NRF2 rise fits a compound supporting the brain's own antioxidant defenses. This is neurons in a dish, not a person, and the sirtuin binding data came out weaker than the reference compounds in initial testing. I would not call this proof that frankincense protects the brain. I would keep frankincense resin and essential oil in an anti-inflammatory routine generally, pair it with a whole-food, lower-sugar diet for insulin sensitivity, and wait for animal data before drawing conclusions about Alzheimer's protection.
Read the full story →




















